Concepedia

Henk van Ooijen

HV

Statistics

Publications

5

Citations

280

H-Index

5

Active since

2014

Affiliations

Philips (Netherlands)(Current)

Philips (Finland)

Henk van Ooijen is an author at Philips (Netherlands) specializing in oncology, signal transduction in cancer, and cancer biomarkers.

Publications per year

2014–2020

5

Publications

5

Selection of Personalized Patient Therapy through the Use of Knowledge-Based Computational Models That Identify Tumor-Driving Signal Transduction Pathways

Wim Verhaegh, Henk van Ooijen, Márcia A. Inda et al. · Cancer Research · 2014 · 98 citations

Medicine, Cancer Biology, Oncology +16

Enabling precision medicine by unravelling disease pathophysiology: quantifying signal transduction pathway activity across cell and tissue types

Anja van de Stolpe, Laurent Holtzer, Henk van Ooijen et al. · Scientific Reports · 2019 · 67 citations · Full text

Life Sciences, Oncology, Pharmacology +15

Assessment of Functional Phosphatidylinositol 3-Kinase Pathway Activity in Cancer Tissue Using Forkhead Box-O Target Gene Expression in a Knowledge-Based Computational Model

Henk van Ooijen, Marten Hornsveld, Christa Dam-de Veen et al. · American Journal Of Pathology · 2018 · 61 citations · Full text

Medicine, Cancer Biology, Oncology +17

A Molecular Test for Quantifying Functional Notch Signaling Pathway Activity in Human Cancer

Kirsten Canté-Barrett, Laurent Holtzer, Henk van Ooijen et al. · Cancers · 2020 · 28 citations · Full text

Medicine, Cancer Biology, Oncology +16

ER and PI3K Pathway Activity in Primary ER Positive Breast Cancer Is Associated with Progression-Free Survival of Metastatic Patients under First-Line Tamoxifen

Anieta M. Sieuwerts, Márcia A. Inda, Marcel Smid et al. · Cancers · 2020 · 26 citations · Full text

Medicine, Endocrinology, Oncology +17

1–5 of 5